I-Mab to Participate at the Piper Sandler Healthcare Conference
I-Mab to Participate at the Piper Sandler Healthcare Conference
The 36th Annual Healthcare Conference will be held in New York, December 3-5, 2024
第36屆年度醫療會議將於2024年12月3日至5日在紐約舉行
ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
馬里蘭州羅克維爾，2024年11月21日 /PRNewswire/ -- 天境生物（納斯達克：IMAb，"公司"）是一家總部位於美國的全球生物科技公司，專注於開發高度差異化的免疫療法用於癌症治療，今天宣佈管理層將於2024年12月4日在派傑投資第36屆年度醫療會議上進行演講。
Piper Sandler 36th Annual Healthcare Conference Presentation Details
派傑投資第36屆年度醫療會議演講詳情
|
Presentation Time |
Wednesday, December 4 at 4:30 p.m. ET |
|
Presenters |
Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer |
|
Webcast link |
Here |
|
Meetings |
One-on-one and small group meetings: December 3 – 4, 2024 |
|
Management |
Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations |
|
演講時間 |
時間：12月4日星期三，東部時間下午4:30 |
|
演講人 |
Sean Fu，博士，MBA，首席執行官 Phillip Dennis，醫學博士，博士，首席醫療官 |
|
網絡視頻鏈接 |
這裏 |
|
會議 |
一對一和小組會議：2024年12月3日至4日 |
|
管理 |
Sean Fu，博士，MBA，首席執行官 Joseph Skelton，首席財務官 Phillip Dennis，醫學博士，博士，首席醫療官 高級董事Tyler Ehler投資者關係 |
The webcast will also be available under "Event Calendar" on I-Mab's IR website
at
網絡視頻鏈接可在I-Mab的IR網站的"活動日曆"中找到。
電話
For more information, please contact your Piper Sandler representative.
如需更多信息，請聯繫您的派傑投資代表。
About I-Mab
關於天境生物
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit and follow us on LinkedIn and X.
天境生物(納斯達克: IMAB)是一家總部位於美國的全球生物科技公司，專注於開發高度差異化的免疫療法用於癌症治療。天境生物在馬里蘭州的羅克維爾和新澤西州的短山建立了運營中心。有關更多信息，請訪問並關注我們在LinkedIn和X上的動態。
For more information, please contact:
更多信息，請聯繫:
Tyler Ehler
Senior Director, Investor Relations
[email protected]
泰勒·埃勒
投資者關係高級總監
[email protected]
SOURCE I-Mab Biopharma
來源：天境生物醫藥
